US2022160899A1PendingUtilityA1

Compositions and methods for delivering messenger rna

Assignee: ARBUTUS BIOPHARMA CORPPriority: Jun 30, 2016Filed: Nov 1, 2021Published: May 26, 2022
Est. expiryJun 30, 2036(~9.9 yrs left)· nominal 20-yr term from priority
A61K 9/0019C12N 15/111B82Y 5/00A61K 47/6911A61K 31/58A61K 9/5123A61K 47/544A61K 47/60A61K 45/06C12N 2320/32A61K 31/713A61K 47/6909A61K 31/573A61K 31/7105A61P 43/00A61K 48/0083
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides compositions comprising nucleic acid molecules, such as mRNA molecules, encapsulated within lipid particles. The compositions are useful, for example, to introduce the mRNA molecules into a human subject where they are translated to produce a polypeptide that functions to ameliorate one or more symptoms of a disease.

Claims

exact text as granted — not AI-modified
1 . A lipid nanoparticle comprising:
 (a) a cationic lipid;   (b) a non-cationic lipid;   (c) a corticosteroid and;   (d) a nucleic acid, wherein the nucleic acid and the corticosteroid are encapsulated within the lipid nanoparticle.   
     
     
         2 - 25 . (canceled) 
     
     
         26 . A lipid nanoparticle formulation comprising a multiplicity of lipid nanoparticles, wherein each lipid nanoparticle comprises:
 (a) a cationic lipid;   (b) a non-cationic lipid; and   (c) mRNA encapsulated within the lipid particle,   
       wherein the lipid nanoparticle formulation has an IFIT response that is no more than 30 fold greater than a reference IFIT response of phosphate buffered saline. 
     
     
         27 - 29 . (canceled) 
     
     
         30 . A lipid nanoparticle comprising:
 (a) a cationic lipid;   (b) a PEG-lipid conjugate present in an amount of at least 3 mole percent; and   (c) mRNA encapsulated within the lipid particle;   
       provided that the lipid particle comprises less than 0.5 mole percent phospholipid. 
     
     
         31 . (canceled)

Join the waitlist — get patent alerts

Track US2022160899A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.